Stocklytics Platform
JSPR
Jasper Therapeutics
JSPRW5
$0.21arrow_drop_down4.05%-$0.00
Penny Stock
JSPR
JSPRW5

$0.21

arrow_drop_down4.05%

Performance History

Chart placeholder
Key Stats
Open$0.21
Prev. Close$0.22
EPS-3.83
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.18
0.22
52 Week Range0.04
0.30
Ratios
Revenue-
EBITDA Margin %-
EPS-3.83

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Jasper Therapeutics (JSPRW)

Jasper Therapeutics, Inc. (JSPRW) is a biotechnology company that focuses on developing innovative treatments for life-threatening blood cancers and hematological conditions. The company is dedicated to improving the lives of patients by providing safer and more effective therapies. Through its cutting-edge research and development efforts, Jasper Therapeutics aims to transform the field of regenerative medicine.
As of the latest market close, the stock price for Jasper Therapeutics, Inc. (JSPRW) was not available. Please refer to reliable financial sources for the most up-to-date stock price information.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add Jasper Therapeutics to watchlist

Keep an eye on Jasper Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Jasper Therapeutics's (JSPRW) price per share?

The current price per share for Jasper Therapeutics (JSPRW) is $0.21. The stock has seen a price change of -$0.01 recently, indicating a -4.05% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Jasper Therapeutics (JSPRW)?

For Jasper Therapeutics (JSPRW), the 52-week high is $0.3, which is 40.85% from the current price. The 52-week low is $0.04, the current price is 432.5% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Jasper Therapeutics (JSPRW) a growth stock?

Jasper Therapeutics (JSPRW) has shown an average price growth of -4.13% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Jasper Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Jasper Therapeutics (JSPRW) stock price performance year to date (YTD)?

As of the latest data, Jasper Therapeutics (JSPRW) has a year-to-date price change of 429.84%. Over the past month, the stock has experienced a price change of 1.57%. Over the last three months, the change has been -1.84%. Over the past six months, the figure is 13.3%.
help

Is Jasper Therapeutics (JSPRW) a profitable company?

Jasper Therapeutics (JSPRW) has a net income of -$64.46M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$68.86M. Furthermore, the EBITDA is -$67.27M.
help

What is the market capitalization of Jasper Therapeutics (JSPRW)?

Jasper Therapeutics (JSPRW) has a market capitalization of $0. The average daily trading volume is 0.21, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level